Searched for
QUARTERLY REVENUE GROWTH
Flexible office space market crosses 100 million sq ft mark, GCCs driving growthIndia's flexible workspace industry wrapped up FY26 on a high note, showcasing impressive double-digit revenue growth alongside rising prof...- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...
- Explained: How SpaceX’s $75 billion IPO could create opportunity for Inox India shareholdersAs Elon Musk's SpaceX heads for a blockbuster IPO, investors are turning their attention to INOX India, a cryogenic technology specialist w...
- MTAR Tech shares crash 9% after 280% rally in a year. What’s spooking investors today?MTAR Technologies shares fell sharply after its key client, Bloom Energy, saw its stock tumble in the US market following the suspension of...
- Explained: Why Oracle shares crashed 10% in extended trading despite earnings beatOracle shares fell sharply in after-hours trading despite beating earnings estimates, as investors reacted to aggressive AI spending plans ...
- Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Order book growth keeps Persistent Systems on trackPersistent Systems shares are rising, buoyed by optimism in the technology sector and advancements in artificial intelligence. The company ...
- AI not a threat, but opportunity for IT services: TCS chairman N ChandrasekaranAddressing the concerns that AI could reduce demand for traditional IT services, Chandrasekaran said the market has misunderstood the relat...
- India eyes more FDI, speed up divestment, asset monetisation as economy faces external risksIndia's government is set to accelerate reforms, focusing on attracting foreign investment and divesting assets. This strategy aims to main...
- GDP growth momentum intact, no need for additional borrowing so far: Govt sourcesIndia's economy is navigating external challenges like rising import costs. However, domestic consumption remains strong, ensuring growth m...
- Wipro shares plunge over 8%. What’s behind the selloff?Wipro shares dropped significantly on Monday. This decline follows the company's share buyback record date. Investors who bought shares for...
- TCS shares slip 2%, down 12% in 4 straight sessions. What’s triggering the decline?TCS shares tumbled 2% Monday, extending a four-day loss to 12%, as rising U.S. bond yields fueled fears of further Federal Reserve rate hik...
- Analysts lift bets on India Inc after strong March quarterAnalysts have upgraded earnings estimates for a majority of NSE 500 companies following better-than-expected profit growth in the March 202...
- Telecom revenue growth may slip to single digits without tariff hikeTelecom revenue growth may slow to single digits this year without tariff increases. Operators are delaying hikes due to inflation. A poten...
- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...
- Ice Make targets Rs 850 cr revenue in FY27, sees new businesses boosting scaleThe company reported record revenue in FY26. Investments impacted profitability, but operating leverage should improve. An order book of Rs...
- HPE lifts forecast past 2028 goals on robust AI demand, shares surge 36%HPE, which competes with Dell and Super Micro Computer, is benefiting as customers increasingly buy its servers and networking products to...
Load More
